AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 282 min read$EHC

Encompass Health’s (NYSE:EHC) Q3 2026 sales top estimates

Encompass Health (EHC) reported Q3 2026 revenue of $1.61B, up 8.9% YoY, beating estimates. Adjusted EPS of $1.52 exceeded expectations. The company raised full-year guidance. Shares fell 2.9% post-results.

Original reporting
finance.yahoo.com
Published Oct 28, 2026, 9:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 10:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Encompass Health’s (NYSE:EHC) Q3 2026 sales top estimates — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$EHCBullishHigh
01

Why it matters

The earnings beat and guidance lift expectations for earnings growth, likely supporting the stock.

02

Market read

First‑report earnings with modest beat; actionable for short‑term positioning.

03

What to watch

Rising operating costs or future payer mix could temper upside.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Encompass Health reported Q3 2026 results, beating revenue and EPS estimates and raising full‑year guidance.

Company-level read

Ticker impact

$EHCBullishHigh confidence
Context

Q3 2026 earnings beat revenue and EPS estimates and raised full-year guidance.

Expected impact

potential upside as the market prices in the earnings beat and higher guidance

Evidence & confidence

The beat and guidance raise earnings expectations, likely attracting buying pressure despite a short-term post‑report dip.

Market effects

Sector

Strong earnings may lift other rehab and health‑services stocks.

Regional

Positive for U.S. healthcare sector sentiment.

Global

Limited to U.S. healthcare investors.

Counterpoint

What could challenge this read

The post‑earnings price dip suggests the market may have over‑reacted to the beat.

Key entities

  • company
    Encompass Health

    U.S. health‑care services provider.

Read at source← All news

StoryEncompass Health posts Q3 2026 results, raises full‑year revenue and EPS guidance

Also covered by

4 outlets

Related articles

OCT 28
$EHCMedAI 8/10

Encompass Health: Q3 Earnings Snapshot

Encompass Health Corp. (EHC) reported Q3 profit of $149.9M, or $1.50 per share, beating estimates. Revenue was $1.61B, also exceeding forecasts. The company expects full-year earnings of $6.23-$6.37 per share and revenue of $6.45B-$6.5B, according to Zacks Investment Research.

finance.yahoo.com1 min
OCT 28
$EHCHigh

Encompass Health reports results for third quarter 2026

Encompass Health Corp (EHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Media Contact October 28, 2026 Polly Manuel, 205 969-4532 polly.manuel@encompasshealth.com Investor Relations Contact Mark Miller, 205 970-5860 mark.miller@encompasshealth.com Encompass Health reports results for third quarter 2026 Increases full-year guidance BIRMIN

SEC EDGAR 8-K2 min
OCT 28
$EHCHigh

Encompass Health reports results for third quarter 2026

Encompass Health (EHC) reported Q3 2026 revenue growth of 8.9% and Adjusted EBITDA growth of 15.5%. The company opened four new hospitals and added 85 beds to existing ones. Full-year guidance was increased. EHC is the largest U.S. operator of inpatient rehabilitation hospitals.

prnewswire.com2 min
SEP 7
$EHCHighAI 8/10

Encompass Health (EHC): This Rehab Hospital Giant Just Raised Its Own Bar Again

Encompass Health (EHC) reported Q2 revenue of $1.597B, up 9.6%, and adjusted EPS of $1.55, up 10.7%. The company raised full-year guidance for revenue, EBITDA, and EPS. It also increased its stock repurchase authorization to $1B. Patient volume and revenue per discharge grew, but free cash flow fell due to higher capital spending. Long-term debt rose to $2.598B.

yahoo.com2 min